CVE-2026-15415
AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.
Executive briefing
A structured intelligence assessment has not yet been generated. The source description is shown above. The background enrichment worker will retry this record.
Evidence confidence: Not assessed Evidence-derived, not an exploitability verdict
Severity & attack characteristics
CVSS vector:CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N
No CVSS vector is currently available in the source record.
Technical explanation & impact
Technical root-cause details are not available in the current source record.
Assess the impact using the published CVSS metrics and the affected vendor component.
Affected products and versions
NVD has not supplied machine-readable vulnerable CPE product/version entries for this CVE. This is an information gap, not proof that no products are affected. Check the vendor advisory references below.
Remediation & validation
- Identify exposure by comparing the affected product and version ranges with your asset inventory, SBOM and externally exposed services.
- Review the linked vendor security advisory or patch notes. Upgrade to a vendor-confirmed fixed release; do not infer a fixed version from the CVE description.
- Until patched, consider restricting network access or disabling the affected feature where operationally safe. These are temporary controls, not a substitute for a vendor fix.
- Validate the remediation with a version check and vulnerability rescan, then retain change evidence.
No fixed version is displayed unless it is explicitly established by a vendor advisory. Follow the vendor's release notes for exact product and branch applicability.